Vitamin K2 Supplementation in Adult Episodic Migraine

Inclusion Criteria: * Adults aged 18 years or above * History of episodic migraine with or without aura since \> 12 months according to the ICHD-3 criteria. * Migraine frequency from 4-14 days per month over the 3 months prior to screening. * Migraine frequency from 4-14 days per month during the baseline period of assessment. * Successful completion of the migraine diary during the baseline evaluation period. Exclusion Criteria: * Migraine patients with superimposed tension type or other forms of primary headaches * Patients who are currently on any of the migraine prophylactic treatments (Sodium valproate, Topiramate, Beta-blockers, Tricyclic antidepressants, SRNI, Flunarizine, Verapamil, Lisinopril, Candesartan) * Patients who have been on any of the previously listed medications within 3 months of screening * Patient who takes the following medications: * Ergotamine or Triptans \> 10 days per month * NSAIDs or paracetamol \> 15 days per month * Opioids more than 4 days per month * Patients on anticoagulants * Other active chronic pain syndromes (i.e. fibromyalgia, painful peripheral neuropathy, post-herpetic neuralgia…) * History of hypersensitivity to the vitamin K2 * History of soy protein, cheese, eggs and meat allergy * History of thrombotic events * Diagnosed coagulopathy or any condition related to coagulation * Cardiovascular event in the past month * Current or planned pregnancy * Lactation * Inability to tolerate oral medications * Known intestinal ma…